U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C28H38N2O5
Molecular Weight 482.6117
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of CILOBRADINE

SMILES

COC1=CC=C(CCN2CCC[C@H](CN3CCC4=CC(OC)=C(OC)C=C4CC3=O)C2)C=C1OC

InChI

InChIKey=OBUFMJDDZTXJPY-NRFANRHFSA-N
InChI=1S/C28H38N2O5/c1-32-24-8-7-20(14-25(24)33-2)9-12-29-11-5-6-21(18-29)19-30-13-10-22-15-26(34-3)27(35-4)16-23(22)17-28(30)31/h7-8,14-16,21H,5-6,9-13,17-19H2,1-4H3/t21-/m0/s1

HIDE SMILES / InChI

Molecular Formula C28H38N2O5
Molecular Weight 482.6117
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Cilobradine is an Hyperpolarization-activated cyclic nucleotide-gated (HCN) channel blocker patented by a pharmaceutical company Boehringer Ingelheim G.m.b.H. for sinus tachycardia treatment. In clinical trials Cilobradine decrease Heart rate. Chronically increased heart rate (HR) is a risk factor for mortality and morbidity with adverse consequences on vascular function, atherogenesis, myocardial ischemia, myocardial energetics and left the ventricular function. Heart rate response was found to be concentration-dependent and appeared with a significant delay with respect to the time course of cilobradine in plasma.

Approval Year

PubMed

PubMed

TitleDatePubMed
Bradycardic and proarrhythmic properties of sinus node inhibitors.
2006 Apr
Patents

Patents

Sample Use Guides

orally once daily over 2 weeks at 0.25–5 mg
Route of Administration: Oral
Substance Class Chemical
Created
by admin
on Sat Dec 16 17:51:48 GMT 2023
Edited
by admin
on Sat Dec 16 17:51:48 GMT 2023
Record UNII
5O1LL04GJ3
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
CILOBRADINE
INN  
INN  
Official Name English
(+)-(S)-3-((1-(3,4-DIMETHOXYPHENETHYL)-3-PIPERIDYL)METHYL)-1,3,4,5-TETRAHYDRO-7,8-DIMETHOXY-2H-3-BENZAZEPIN-2-ONE
Systematic Name English
2H-3-BENZAZEPIN-2-ONE, 3-(((3S)-1-(2-(3,4-DIMETHOXYPHENYL)ETHYL)-3-PIPERIDINYL)METHYL)-1,3,4,5-TETRAHYDRO-7,8-DIMETHOXY-
Systematic Name English
2H-3-BENZAZEPIN-2-ONE, 3-((1-(2-(3,4-DIMETHOXYPHENYL)ETHYL)-3-PIPERIDINYL)METHYL)-1,3,4,5-TETRAHYDRO-7,8-DIMETHOXY-, (S)-
Common Name English
cilobradine [INN]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C47793
Created by admin on Sat Dec 16 17:51:48 GMT 2023 , Edited by admin on Sat Dec 16 17:51:48 GMT 2023
Code System Code Type Description
INN
6641
Created by admin on Sat Dec 16 17:51:48 GMT 2023 , Edited by admin on Sat Dec 16 17:51:48 GMT 2023
PRIMARY
FDA UNII
5O1LL04GJ3
Created by admin on Sat Dec 16 17:51:48 GMT 2023 , Edited by admin on Sat Dec 16 17:51:48 GMT 2023
PRIMARY
CAS
147541-45-5
Created by admin on Sat Dec 16 17:51:48 GMT 2023 , Edited by admin on Sat Dec 16 17:51:48 GMT 2023
PRIMARY
ChEMBL
CHEMBL2105984
Created by admin on Sat Dec 16 17:51:48 GMT 2023 , Edited by admin on Sat Dec 16 17:51:48 GMT 2023
PRIMARY
EVMPD
SUB06270MIG
Created by admin on Sat Dec 16 17:51:48 GMT 2023 , Edited by admin on Sat Dec 16 17:51:48 GMT 2023
PRIMARY
MESH
C490484
Created by admin on Sat Dec 16 17:51:48 GMT 2023 , Edited by admin on Sat Dec 16 17:51:48 GMT 2023
PRIMARY
NCI_THESAURUS
C81347
Created by admin on Sat Dec 16 17:51:48 GMT 2023 , Edited by admin on Sat Dec 16 17:51:48 GMT 2023
PRIMARY
EPA CompTox
DTXSID80933145
Created by admin on Sat Dec 16 17:51:48 GMT 2023 , Edited by admin on Sat Dec 16 17:51:48 GMT 2023
PRIMARY
SMS_ID
100000081032
Created by admin on Sat Dec 16 17:51:48 GMT 2023 , Edited by admin on Sat Dec 16 17:51:48 GMT 2023
PRIMARY
PUBCHEM
9869877
Created by admin on Sat Dec 16 17:51:48 GMT 2023 , Edited by admin on Sat Dec 16 17:51:48 GMT 2023
PRIMARY
Related Record Type Details
ACTIVE MOIETY